ICON plc shared on LinkedIn:
“Healthcare technology and data availability now offer innovative solutions to mitigate barriers to enrolling representative populations.
Our latest blog explores how sponsors can meet regulatory requirements using evidence-based analysis, patient-centric strategies and innovative AI solutions.
Discover a holistic approach to driving diversity in oncology trials.”
Source: ICON plc/LinkedIn